Advertisement

Topics

Top Pharmaceutical Companies in India Reports

22:28 EDT 23rd September 2018 | BioPortfolio

20182023 China Capecitabine Market Report Status and Outlook [Report Updated: 13032018] Prices from USD $3360

In 2017, the Capecitabine market size was xx million USD in China, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In China market, the top players include Roche Teva Mylan Hikma Hengrui Medicine Cipla Reliance Group HeteroSplit by product types/category, covering 500 mg 150 mgSplit by applications/end use industries, covers Breast C...

Glenmark Pharmaceuticals Ltd GLENMARK Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17042018] Prices from USD $250

SummaryGlenmark Pharmaceuticals Ltd Glenmark is a pharmaceutical company which focuses on the discovery of new chemical entities NCEs and new biological entities NBEs. The company's formulations business encompasses therapeutic areas such as dermatology, antiinfective, respiratory, cardiac, diabetes, gynecology, central nervous system, and oncology. It also offers a wide range of generic products....

Cipla Ltd CIPLA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16042018] Prices from USD $250

SummaryCipla Ltd Cipla is a global pharmaceutical company which focuses on providing high quality affordable medicines. It researches, develops, manufactures and commercializes a wide range of pharmaceutical products including active pharmaceutical ingredients APIs, formulations and animal healthcare products. The company also offers overthecounter OTC products and a range of inhalation medication...

Cadila Pharmaceuticals Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryCadila Pharmaceuticals Ltd Cadila Pharmaceuticals is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. Its products include active pharmaceutical ingredients API and pharmaceutical formulations. The company's products are in the form of capsules, tablets, orals, soft and hard gelatin capsules, and liquid solutions. Its business operations includes...

Biocon Ltd BIOCON Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16042018] Prices from USD $250

SummaryBiocon Ltd Biocon is a global biopharmaceutical company specialized in biopharmaceuticals and research services. The company produces a wide range of active pharmaceutical ingredients APIs, branded formulations; and complex biologics both novels and biosimilars including monoclonal antibodies MAbs, rhInsulin and insulin analogs. Its core therapeutic areas include diabetes, cancer and autoim...

Torrent Pharmaceuticals Ltd TORNTPHARM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryTorrent Pharmaceuticals Ltd Torrent manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastrointestinal, diabetology, antiinfective and pain management segments. Also, the company has presence in nephrology, cancer, gynecology and pediatric segments. Torrent has a fully equipped research center that is appr...

20182023 UK Capecitabine Market Report Status and Outlook [Report Updated: 13032018] Prices from USD $3360

In 2017, the Capecitabine market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In UK market, the top players include Roche Teva Mylan Hikma Hengrui Medicine Cipla Reliance Group HeteroSplit by product types/category, covering 500 mg 150 mgSplit by applications/end use industries, covers Breast Cancer ...

Lupin Ltd LUPIN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryLupin Ltd Lupin focuses on the development and manufacture of generic and branded formulations, biotechnology products and active pharmaceutical ingredients APIs. The company has expertise in the areas of cardiovascular, asthma, diabetology, pediatrics, central nervous system, gastrointestinal, antiinfectives, NSAIDs, antiTB and cephalosporins. It undertakes extensive research and developme...

20182023 India Capecitabine Market Report Status and Outlook [Report Updated: 13032018] Prices from USD $3360

In 2017, the Capecitabine market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In India market, the top players include Roche Teva Mylan Hikma Hengrui Medicine Cipla Reliance Group HeteroSplit by product types/category, covering 500 mg 150 mgSplit by applications/end use industries, covers Breast C...

Cadila Pharmaceuticals Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11072018] Prices from USD $250

SummaryCadila Pharmaceuticals Ltd Cadila Pharmaceuticals is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. Its products include active pharmaceutical ingredients API and pharmaceutical formulations. The company's products are in the form of capsules, tablets, orals, soft and hard gelatin capsules, and liquid solutions. Its business operations includes...

Cipla Limited Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 26062018] Prices from USD $350

Cipla Limited Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Cipla Limited Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Cipla Limited ...

20182023 Malaysia Capecitabine Market Report Status and Outlook [Report Updated: 13032018] Prices from USD $3360

In 2017, the Capecitabine market size was xx million USD in Malaysia, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In Malaysia market, the top players include Roche Teva Mylan Hikma Hengrui Medicine Cipla Reliance Group HeteroSplit by product types/category, covering 500 mg 150 mgSplit by applications/end use industries, covers Br...

20182023 Philippines Capecitabine Market Report Status and Outlook [Report Updated: 13032018] Prices from USD $3360

In 2017, the Capecitabine market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In Philippines market, the top players include Roche Teva Mylan Hikma Hengrui Medicine Cipla Reliance Group HeteroSplit by product types/category, covering 500 mg 150 mgSplit by applications/end use industries, covers...

GLOBAL BOTANICAL PLANT DERIVATIVE DRUG MARKET FORECAST 20182026 [Report Updated: 15012018] Prices from USD $2500

KEY FINDINGSThe Global Botanical and plantderivative drug market was estimated to be worth $ 26621 million in 2017. Due to the growing application of these drugs in several diseases, the market is expected to witness a rise in CAGR of 8.58% for the forecast years of 20182026 and is predicted to reach a worth of $53850 million by its end.MARKET INSIGHTSThe global botanical and plantderivative drug ...

Glenmark Pharmaceuticals Limited Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15022018] Prices from USD $350

Glenmark Pharmaceuticals Limited Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Glenmark Pharmaceuticals Limited Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership tra...

Global and China Ketorolac Market Research by Company, Type Application 20132025 [Report Updated: 06032018] Prices from USD $2000

SummaryMarket Segment as follows:By Type Orange Oil Bergamot Oil Lemon Oil Lime Oil Mandarin Oil Grapefruit OilBy Application Medical Uses Chemistry Uses OthersBy Company Allergan DeepCare Health Cadila FDC Intas Laboratories Gufic Chem Ranbaxy Adley Formulation Neon Laboratories Sun Pharmaceutical Industries Cipla Dallas P

Glenmark Pharmaceuticals Ltd GLENMARK Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryGlenmark Pharmaceuticals Ltd Glenmark is a pharmaceutical company which focuses on the discovery of new chemical entities NCEs and new biological entities NBEs. The company's formulations business encompasses therapeutic areas such as dermatology, antiinfective, respiratory, cardiac, diabetes, gynecology, central nervous system, and oncology. It also offers a wide range of generic products....

Cadila Healthcare Ltd CADILAHC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15022018] Prices from USD $250

SummaryCadila Healthcare Ltd Cadila is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The company's product portfolio includes active pharmaceutical ingredients APIs, formulations, wellness and animal health products. Cadila's products find application in the treatment of disease related to gastrointestinal, cardiovascular, ...

Dr. Reddy's Laboratories Limited Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 18022018] Prices from USD $350

Dr. Reddy's Laboratories Limited Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Dr. Reddy's Laboratories Limited Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership tra...

EUROPE BOTANICAL PLANT DERIVATIVE DRUG MARKET FORECAST 20182026 [Report Updated: 15012018] Prices from USD $1250

KEY FINDINGSThe Europe botanical and plant derivative drug market is predicted to be worth $10 billion by the end of 2026. The market is expected to grow at a CAGR of 7.96% over the forecast period of 20182026.MARKET INSIGHTSIncreasing demand for traditional medicines, their growing applications in diseases and the increasing number of approvals from the FDA are chiefly responsible for driving the...

20152023 World 5Aminosalicylic Acid Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 23022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

ASIA PACIFIC BOTANICAL PLANT DERIVATIVE DRUG MARKET FORECAST 20182026 [Report Updated: 15012018] Prices from USD $1250

KEY FINDINGSThe AsiaPacific botanical and plant derivative drug market is predicted to rise at 9.01% CAGR over the forecast period of 20182026. The market is driven by the rising investment of pharmaceutical companies and increased integration of plantderived drugs in the market.MARKET INSIGHTSThe market is segmented on the basis of plantderived drug type, products, and therapeutic applications. T...

Glenmark Pharmaceuticals Ltd GLENMARK Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12032018] Prices from USD $250

SummaryGlenmark Pharmaceuticals Ltd Glenmark is a pharmaceutical company which focuses on the discovery of new chemical entities NCEs and new biological entities NBEs. The company's formulations business encompasses therapeutic areas such as dermatology, antiinfective, respiratory, cardiac, diabetes, gynecology, central nervous system, and oncology. It also offers a wide range of generic products....

Cadila Pharmaceuticals Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27022018] Prices from USD $250

SummaryCadila Pharmaceuticals Ltd Cadila Pharmaceuticals is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. Its products include active pharmaceutical ingredients API and pharmaceutical formulations. The company's products are in the form of capsules, tablets, orals, soft and hard gelatin capsules, and liquid solutions. Its business operations includes...

Global and North America Cephalosporin Market Status and Future Forecast 20132023 [Report Updated: 02022018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:North America Market by company, Type, Application RegionPart 46:Key Regions of North America Market by Type, ApplicationPart 7:Company information, Sales, Cost, Margin etc.Part 8:ConclusionMarke...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Top Pharmaceutical Companies in India market research data and corporate reports here